Alcohol Dependence Expansion NY Ketamine Infusions recently launched a program for ketamine treatment of alcohol dependence, signaling a growth vector in addiction care. This creates a sales opportunity to partner with addiction treatment centers, rehab facilities, and hospitals to co-manage patients or provide white-label infusion services. Emphasize cross-referrals and bundled care under payer networks.

Clinician Credibility Founder and Medical Director Dr. Glen Brooks is a board-certified anesthesiologist with Harvard training, widely recognized as a leading ketamine infusion expert. Leverage this credibility to establish partnerships with health systems, mental health clinics, employers, and payer networks, plus opportunities for speaking engagements and clinical collaborations. This can accelerate referrals and co-branding.

NYC Market Focus Based in New York City with a track record of treating over 8,000 patients, the company has strong local brand recognition and access to dense healthcare networks. Target regional hospital systems, primary care groups, and corporate wellness programs in NYC for referrals or joint programs, with potential to expand to nearby markets.

Partnership Growth As a small to mid-sized clinic with 11-50 employees and under 1M in revenue, NY Ketamine Infusions presents a scalable opportunity for strategic partnerships, including provider training, infusion protocol consulting, and white-label services for other clinics. Structured partnerships could accelerate patient flow and diversify revenue streams beyond a single clinic location.

Growth Marketing The company already uses digital marketing and analytics tools (Facebook Pixel, Google Analytics/Tag Manager, etc.), signaling readiness for data-driven patient acquisition. A focused growth marketing partnership could optimize lead generation, referral channel performance, and patient retention, while ensuring regulatory and privacy compliance.